Heritage Cannabis Holdings Corp. (C:CANN)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | Suite 600-77 Bloor Street TORONTO ON M5S 1M2 |
| Tel: | N/A |
| Website: | https://heritagecann.com |
| IR: | See website |
| Key People | ||
| Clinton B. Sharples Chairman of the Board | David Schwede President, Chief Executive Officer, Director | Umar Syed Corporate Secretary, President - U.S. and International Medical Products |
| Jasmine Paige Interim Chief Financial Officer | Eoin Hegarty Chief Operating Officer | Cory Larsen Chief Commercial Officer |
| Business Overview |
| Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company. |
| Financial Overview |
| For the nine months ended 31 July 2023, Heritage Cannabis Holdings Corp revenues increased 1% to C$21.8M. Net loss totaled C$6.1M vs. income of C$2.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Unrealized gain (loss) on contingent con decrease from C$8.3M (income) to C$0K, Salaries, wages and benefits increase of 31% to C$6.6M (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $21.63M as of Jul 31, 2023 |
| Annual revenue (TTM): | $29.85M as of Jul 31, 2023 |
| EBITDA (TTM): | -$8.01M as of Jul 31, 2023 |
| Net annual income (TTM): | -$33.42M as of Jul 31, 2023 |
| Free cash flow (TTM): | -$1.23M as of Jul 31, 2023 |
| Net Debt Last Fiscal Year: | $10.62M as of Jul 31, 2023 |
| Shares outstanding: | 943,009,230 as of Jul 31, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2023 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.